Our research from 2024 highlights that significant concerns remain regarding transparency, information sharing and criminal justice in the global fight against wildlife crime. This report is part of EIA's regular assessment and focuses on four themes, which build upon the findings of our previous work.
EIA’s research, conducted over the past two years, reveals the continued online availability of at least 88 traditional Chinese medicine (TCM) products stated to contain leopard, pangolin and, in a few cases, tiger and rhino, manufactured by 72 Chinese companies which have been licensed by the National Medical Products Administration of China.
This comprehensive toolkit brings together in one place a range of measures and resources that governments of tiger range countries can use to counter trafficking of tigers, their parts and derivatives – including from farmed tigers.
Ahead of the 74th Meeting of the Standing Committee of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), EIA has prepared comments and recommendations on agenda items relating to Elephants, Pangolins, Tigers and other Asian Big Cats, Rhinos, Totoaba, Saiga, enforcement and compliance matters.
Tackling wildlife crime, stepping up anti-corruption efforts and enhancing access to information and justice are key to achieving the United Nations Sustainable Development Goals.
EIA has prepared analysis of the draft revision of China's Wildlife Protection Law, published for public comment in October 2020, along with recommendations for further revisions urgently needed to secure positive changes for threatened wildlife, including tigers, leopards, pangolins, elephants, rhinos and bears.